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Abstract
Purpose With X-ray radiation protection and dose man-
agement constantly gaining interest in interventional radiol-
ogy, novel procedures often undergo prospective dose stud-
ies using anthropomorphic phantoms to determine expected
reference organ-equivalent dose values. Due to inherent un-
certainties, such as impact of exact patient positioning, gen-
eralized geometry of the phantoms, limited dosimeter posi-
tioning options, and composition of tissue-equivalent mate-
rials, these dose values might not allow for patient-specific
risk assessment. Therefore, first the aim of this study is to
quantify the influence of these parameters on local X-ray
dose to evaluate their relevance in the assessment of patient-
specific organ doses. Second, this knowledge further enables
validating a simulation approach, which allows employing
physiological material models and patient-specific geome-
tries.
Methods Phantom dosimetry experiments using MOSFET
dosimeters were conducted reproducing imaging scenarios
in prostatic arterial embolization (PAE). Associated organ-
equivalent dose of prostate, bladder, colon and skin was de-
termined. Dose deviation induced by possible small displace-
ments of the patient was reproduced by moving the X-ray
source. Dose deviation induced by geometric and material
differences was investigated by analyzing two different com-
monly used phantoms. We reconstructed the experiments us-
ing Monte Carlo (MC) simulations, a reference male geom-
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etry, and different material properties to validate simulations
and experiments against each other.
Results Overall, MC simulated organ dose values are in
accordance with the measured ones for the majority of cases.
Marginal displacements of X-ray source relative to the phan-
toms lead to deviations of 6 % to 135 % in organ dose val-
ues, while skin dose remains relatively constant. Regarding
the impact of phantom material composition, underestima-
tion of internal organ dose values by 12 % to 20 % is preva-
lent in all simulated phantoms. Skin dose, however, can be
estimated with low deviation of 1 % to 8 % at least for two
materials.
Conclusions Prospective reference dose studies might not
extend to precise patient-specific dose assessment. There-
fore online organ dose assessment tools, based on advanced
patient modeling and MC methods are desirable.
Keywords Anthropomorphic phantom · Dosimetry ·
MOSFET · Monte Carlo simulation · Prostatic artery
embolization
1 Introduction
Over the last decades, the number of fluoroscopically-guided
interventions (FGI) increased considerably, putting a stronger
focus on radiation protection, management, and safety for
both patients and radiologists. In contrast to diagnostic ra-
diology, complex FGIs, such as prostatic artery emboliza-
tion (PAE), may require long fluoroscopic times or high-
quality images, leading to increased radiation exposure [1],
and therefore considerable deterministic and stochastic risks
induced by the ionizing radiation.
First, in general deterministic risks may include skin in-
juries, also referred to as radiation dermatitis, and other ob-
servable adverse effects such as hair loss during neuro-interventional
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procedures [2,3,4,5]. Deterministic consequences are usu-
ally assessed based on the entrance peak skin dose (PSD),
the highest irradiation accumulated on the patient’s skin.
The PSD can be (1) measured directly using radiochromic
film or comparable dosimeters, or (2) estimated indirectly
based on the air kerma at the interventional reference point
(KIRP) and dose-area-products (DAP), which are typically
measured in Gy and Gycm2, respectively [6].
Second, stochastic risks mainly describe the increased
probability to develop some form of cancer. This risk is quan-
tified using either effective dose (E) or tissue-specific equiv-
alent doses (HT ). Both are usually measured in Sv, however,
since X-rays only include photon and electron interactions,
HT values can also be given with respect to Gy. While E is
typically correlated linearly with the measured DAP, its us-
age as only risk estimator is dissuaded since it is determined
with respect to a reference human model and a specific, re-
producible procedure, which is not given in interventional
radiology necessarily [1,7]. In general, the direct measure-
ment of E and HT is not feasible in-vivo and only possible
in phantom or simulation studies.
Most FGIs are performed to treat potentially fatal condi-
tions, and resulting high dose values are therefore justified
evidently. However, radiation doses applied during proce-
dures aimed at improving quality of life mainly, such as dur-
ing PAE, have to be weighed against the benefit of the proce-
dure more strictly. Recently, PAE gained a notable increase
in popularity as a primary treatment for benign prostatic hy-
perplasia [8,9,10]. Since PAE heavily relies on fluoroscopic
guidance, digital subtraction angiography (DSA), and cone-
beam computed tomography (CBCT), patients’ skin and ef-
fective dose, as well as the radiation exposure of the treating
medical staff are serious concerns and may vary consider-
ably between different procedures [11,12].
So far, the patient exposure during PAEs has mostly been
assessed based on the PSD, measured directly using radio-
chromic film [11,13], or based on KIRP and DAP [14,15,
16]. At the time of this study, there has been only one (phan-
tom) study focused on patient E orHT values published [13].
However, it is challenging to generalize (phantom) study re-
sults to specific patients and procedures as there are mul-
tiple sources of uncertainty involved. For instance, patient
anatomy and placement may vary notably between proce-
dures, leading to increased or reduced organ dose for spe-
cific irradiated organs. In addition, FGIs are less reproducible
as diagnostic CTs, as they might require patient-specific work-
flow adaptations over the course of the intervention. This is
further underlined in the example of PAE, where large devi-
ations in fluoroscopic time, number of DSA images, usage
of CBCT, and overall PSD have been reported [13].
It still remains questionable, whether predetermined ex-
pected reference E or HT values are sufficient to pro-actively
assess and plan radiation exposure online. Instead, employ-
ing online or even retrospective Monte Carlo (MC) simu-
lation of the radiation transport inside the patient seem at-
tractive to actually estimate patient- and procedure-specific
dose values that allow for the individual risk assessment. Al-
though MC methods usually introduce high computation la-
tency, there exist successful implementations making use of
GPU acceleration [17,18]. To this end, we combine empiric
dose measurements using dedicated anthropomorphic phan-
toms, and MC simulations of the same experimental setup to
estimate organ doses of directly irradiated organs. By vary-
ing input parameters, such as material composition or pa-
tient placement, the impact of small uncertainties can be
quantified, underlining the need for individual and specific
dose estimation.
2 Materials and Methods
2.1 Anthropomorphic phantoms
To measure organ dose, we employed two anthropomorphic
phantoms specifically designed for dosimetry purposes, the
adult male RANDO phantom (AR), the predecessor of the
Alderson Radiation Therapy phantom (RANDO, Radiology
Support Devices, Inc., Long Beach, CA, USA), and the adult
male ATOM phantom (CA) (ATOM Adult Male Model 701,
Computerized Imaging Reference Systems, Inc., Norfolk,
VA, USA).
2.1.1 Alderson RANDO (AR)
The AR comprises 34, 2.5 cm thick, axial slices along the
trunk and head, and a 15 cm thick slice of the legs, mea-
suring 97.5 cm in total. It consists of a human skeleton em-
bedded in a synthetic isocyanate rubber compound, which
is tissue-equivalent with respect to linear attenuation over
the energy range typically used in external radiation ther-
apy. The AR phantom was shown to be water-equivalent
with 94±1% accuracy for 70 kVp spectra; however, this de-
viation has to be considered in diagnostic and interventional
radiology dosimetry [19]. Cavities to place dosimeters are
uniformly distributed over each slice except where bone is
located. Unfortunately, the literature gives ambiguous infor-
mation on the exact composition of the used rubber com-
pound, stating (1) it is water-equivalent, (2) it is in accor-
dance with the standard as proposed in the 44th report of
the International Commission on Radiation Units and Mea-
surements (ICRU), or (3) the composition of elements by
fraction of mass [19,20].
2.1.2 CIRS ATOM (CA)
The CA comprises 39, 2.5 cm thick, axial slices along head,
trunk and legs, measuring 97.5 cm in total. It consists of av-
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(a) Section 34. (b) Section 35. (c) Skin entry. (d) Skin exit. (e) X-ray.
Fig. 1: MOSFET dosimeter equipping and exemplary time-averaged acquisition of the CA phantom.
(a) Section 33. (b) Section 34. (c) Skin entry. (d) Skin exit. (e) X-ray.
Fig. 2: MOSFET dosimeter equipping and exemplary time-averaged acquisition of the AR phantom.
(a) Placement of the CA phan-
tom.
(b) Placement of the AR phan-
tom.
(c) Central interface. (d) Interface above. (e) Interface below.
Fig. 3: Experiment setup and phantom placement.
eraged materials for soft/adipose, bone, lung (inhale) and
brain tissue, which are tissue-equivalent with respect to lin-
ear attenuation in the range of 50 keV to 15 MeV. In con-
trast to the AR phantom, the cavities to place dosimeters
are uniformly distributed over each slice of the phantom and
all present tissue types. In addition, the manufacturer offers
commercially available organ maps for each slice, which in-
dicate the contours of internal radio-sensitive organs and po-
tential dosimeter cavities to cover these. The composition of
each processed tissue-equivalent material is supplemented
with respect to the contributing fraction of mass of each el-
ement.
2.2 Dosimeters
For the assessment of organ dose, we used high-sensitivity
metal oxide semiconductor field effect transistor (MOSFET)
dosimeters TN 1002RD-H, equipped to a mobile reader (mo-
bileMOSFET system, model TN-RD-70-W, Best Medical
Canada Ltd., Ottawa, ON, Canada). The mobileMOSFET
system consists of remote monitoring dose verification soft-
ware, a Bluetooth wireless transceiver, and reader module
that act as channel between MOSFET probes and software.
Up to five MOSFETs can be connected to one reader.
Prior to the measurements, all MOSFET detectors were
calibrated. For calibration purposes, each of used MOSFETs
were irradiated with a specified dose level. The dose level
was measured with an 530 cm3 ionization chamber (PM500-
CII 52.8210, Capintec Inc., Ramsey, NJ, USA) connected to
the Unidos dosimeter (PTW, Freiburg, Germany). The ion-
ization chamber was calibrated by PTW accredited by the
German National Accreditation Body (D-K 15059-01-00)
as calibration laboratory in the Deutschen Kalibrierdienst
(German calibration service). The mobileMOSFET software
calculates automatically the calibration factor as the ratio
of the measured voltage value to the actual value of radia-
tion dose for every single MOSFET probe. According to the
manufacturer, the uncertainty of the used MOSFET probes
is below 3 % at 20 cGy, for instance. Extrapolating the man-
ufacturer’s data, the uncertainty is below 11 % at 20 mGy.
2.3 Phantom equipping
The MOSFET probes are distributed over two axial slices
(section 34 and 35) of the CA phantom, and the entry and
exit point of the X-ray on the phantom surface. Following
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the manufacturer’s organ maps, 11 measurement points (MP)
cover prostate (3), bladder (6), and colon (2). The skin en-
trance dose is monitored by five dosimeters and the remain-
der of dosimeters monitors the exit dose. The skin exit dose
is measured mainly to validate MC simulation and experi-
mental measurements against each other robustly. Internally
placed MOSFET dosimeters are placed in soft-tissue-equivalent
holders to reduce the impact of air in the cavity, thus super-
seding corrective calculations based on a certain cavity the-
ory. All dosimeters are fixed using X-ray-transparent low-
adhesive tape; the exact placement is shown in Figure 1.
Accordingly, the AR phantom is equipped. Since over-
all anatomy and cavity spacing of both used phantoms dif-
fer slightly, we could only approximate the positioning of
the MOSFET probes to match the CA. Unfortunately, the
section embedding the prostate is part of the bottom slice,
which does not contain any cavities for dosimeters. There-
fore, the closest sections (section 33 and 34) and cavities
are equipped with MOSFET dosimeters and the respective
section identification numbers do not coincide with the sec-
tions of the CA phantom. The exact probe placement is doc-
umented in Figure 2.
2.4 Experiment setup
To simplify replicability and comparability between con-
ducted, future, and possible replication phantom studies, the
phantoms are placed upright and the X-ray system’s C-arm
is rotated by 90◦ as shown in Figure 3a and 3b, which is
equivalent to anteroposterior position. It is important to note
that, during PAE, the X-ray system is usually rotated to an
ipsilateral angle of 25◦ to 35◦. However, to balance perti-
nence, reproducibility, and generalizability of this study, we
decided to trivialize the experimental setup. This approach
also yields the advantage of eliminating uncertainties re-
lated to the multitude of available different interventional
or surgery tables and mattresses. During all conducted ex-
periments, the same Artis zeego imaging system (Siemens
Healthcare GmbH, Erlangen, Germany) is used. The dis-
tance between X-ray tube and central longitudinal axis of
both phantoms is 800 mm, and the overall source-to-image
distance (SID) is 1200 mm. The central X-ray is aligned
with the interface of two axial sections using the built-in
detector laser cross. To investigate the impact of patient po-
sitioning and navigation of the C-arm on organ dose, three
section interfaces are exposed for each phantom. First, the
interface between both sections that are equipped with MOS-
FET dosimeters is irradiated, followed by the interfaces 25
mm above and below of it as shown in Figure 3c, 3d, and 3e.
These deviations are assumed to cover the possible patient
position variations between different PAE procedures.
In order to secure sufficient exposure of all MOSFET
probes, 40 s X-ray acquisitions with 30 frames per second
are recorded. The measurements are repeated three times
for each image setting. The peak tube voltage is 70 kV and
neither additional filtration nor collimation is applied. Auto-
matic exposure control is deactivated resulting in a constant
accumulated air kerma of 40.8 mGy per acquisition, which
is directly monitored by an online ionization chamber. After
each angiography acquisition, the dosimeters are read out
and the measured dose values for each MP are averaged.
With only photons and electrons being involved, the result-
ing organ-equivalent dose HT values are then given by the
mean of all averaged MPs of the regarded organ, as the ra-
diation weighting factor is wR = 1 for these particles. All
measurements are taken on the same day using the same
MOSFET devices and same equipping for both phantoms.
Figure 1e and 2e showcase time-averaged acquisitions for
both investigated phantoms.
2.5 Monte Carlo simulation
Geant4 [23] provides a customizable, flexible, and object-
oriented interface to its open-source kernel written in C++
and was therefore used for the simulations. Although Geant4
stems from the high energy physics community, it is also
well extensible to medical physics and features specific low-
energy physical models [24]. Four MC codes applicable to
diagnostic X-ray dosimetry, namely EGSnrc, Geant4, MC-
NPX, and Penelope have been evaluated by the American
Association of Physicists in Medicine [21]. To ensure valid-
ity of our particular Geant4-based application, we evaluated
it using the test cases 1 and 2 as proposed by the Ameri-
can Association of Physicists in Medicine [21]. No striking
features were observed.
2.5.1 Digital phantom
To employ the investigated phantoms in the MC simula-
tion, we use the geometry of the reference voxel phantom
Golem provided by the former Institute of Radiation Protec-
tion, which is now integrated into the Institute of Innovative
Radiotherapy1. The Golem phantom is an implementation
of the male reference human as recommended by the In-
ternational Commission on Radiological Protection (ICRP)
[25]. The 176 cm tall phantom consists of 220 slices with
256×256 voxels each, ranging from the vertex down to the
toes. The voxels have a volume of 8 mm×2.08 mm×2.08
mm and are segmented and labeled with respect to 122 or-
gans and individual bones.
Four different voxel-wise material composition mappings
are used to assign material properties to the associated la-
bels. The first material composition represents the CA phan-
tom. Two material composition mappings reference the AR
1 www.helmholtz-muenchen.de/en/institute-of-innovative-
radiotherapy/index.html, accessed January 28th 2019
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phantom in two different implementations, according to lit-
erature [19,20]. First, one implementation follows the widely
accepted material composition as proposed by White [20].
Second, the other implementation of the AR phantom (ARW)
models soft and adipose tissue as water, which is a widely
used simplification for soft and adipose tissue. The fourth
material mapping serves as reference mapping (R) and is
modeled to resemble a living adult male, following the ma-
terial specifications proposed by the ICRP standard. It com-
prises adipose, soft, skin, brain, bone (cortical), muscle, and
lung (inhale) tissue. The skin of the phantom consists of a
one voxel thick layer.
2.5.2 Simulation setup
The phantom is centered in the origin of the world coordi-
nate system, and the particle source is placed in 800 mm dis-
tance anteroposterior to the phantom, such that the prostate
lies approximately in the center of the photon beam. The
particle source radius is 0.6 mm and collimated to cover the
same field as the manual dose measurements, resulting in
aperture angles of 7.02◦ and 9.04◦. However, the resulting
field size is indifferent, since the automatic exposure con-
trol is not active in the real-world experimental setup. Emit-
ted photon vertices are sampled using cosine-weighting to
obtain homogeneous fluence with respect to a sphere sur-
face. The underlying energy spectrum of the photon shower
is modeled considering a tungsten anode, 70 kV peak volt-
age, and 2.7 mm aluminum self-filtration using Boone’s al-
gorithm [26]. Photon and electron interactions follow the
standard low-energy electromagnetic physics defined in the
Geant4 kernel (option 4), which is mainly based on the Liv-
ermore [27,28,29] and Penelope [22] models. The same Geant4
physics implementation was used in TG-195 [21].
To obtain stable dose distributions, 10×108 primary pho-
ton histories are simulated. Dose distributions are scored
with respect to the energy dose D absorbed by each voxel
measured in Gy. The simulation is carried out in batches of
108 primaries in order to bring variance to the initial random
seed and to split the computation to several nodes of the high
performance computing (HPC) cluster. Each batch compu-
tation lasts on average 3.5 h; however multiple batches are
processed in parallel. The resulting dose distributions have
the same resolution as the associated phantom volume. The
simulated dose distributions are calibrated, such that the sim-
ulated primary and experimentally measured mean air kerma
are equal. This conversion is valid, since electric or collision
kerma and absorbed dose are equivalent when charged par-
ticle equilibrium is present, which can be assumed for air
inside of the primary photon beam.
Eventually, HT is calculated by averaging the dose ab-
sorbed in all voxels associated with a monitored organ. In
addition, using MC dose estimation, maximum dose values
can be reported, which are of major interest regarding large
organs that are irradiated unevenly. Due to limited MPs be-
ing available, this is not possible in experimental studies. For
large organs, such as skin and colon, only voxels that are ir-
radiated directly are considered to obtain results consistent
with the conducted dose measurements.
3 Results
3.1 Dose measurements
Table 1 summarizes the experimental organ-equivalent dose
HT values for prostate, bladder, colon, and skin for the cen-
tral section interface and ±25 mm offset for both anthropo-
morphic phantoms as well as the corresponding exit dose.
Overall, a high agreement between CA and AR phantoms
can be reported for the majority of internal organs, except
the colon, within 92 % to 100 % accordance. The measured
HT values for the colon differ by 21 % between both phan-
toms in one case. Regarding skin dose, deviations of 13
% in average are observable, where the AR phantom over-
estimates the skin entrance dose in comparison to the CA
phantom. The exit dose shows higher variation, however, the
measured values are in the same order of magnitude.
3.2 Impact of phantom placement
To quantify the uncertainty induced by phantom (and pa-
tient) positioning, the influence of marginal displacements
along the longitudinal axis by ±25 mm has been investi-
gated. To this end, the measured HT values for ±25 mm
translation are set in relation to measured HT values for
the original position and the resulting ratios are listed in
Table 2. The impact of displacement of the field of view
in both directions is of similar magnitude for both phan-
toms. However, translation by +25 mm leads to deviations
up to 24 % to 73 % regarding the mostly irradiated organs
prostate and bladder, while translation in the opposite direc-
tion produces modest deviation ranging from 6 % to 19 %.
The skin dose is almost constant for both phantoms and±25
mm translation with a maximum deviation of 5 %. Taking
all monitored organs into account, the translation-induced
deviation from the original field of view is 46 % in average,
however, with values ranging from 6 % to 135 %. The exit
dose varies by up to 43 %.
3.3 Monte Carlo simulation
Figure 4a to 4d show an exemplary axial slice of the MC
simulated dose distributions inside the digital Golem phan-
tom at the height of the prostate for all four material map-
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Table 1: Measured organ-equivalent dose HT values from X-ray exposure of the central section interface and ±25 mm offset
as shown in Figure 3c, 3d, and 3e. Data is shown as mean and standard deviation of all dosimeter readings per organ of all
acquisitions per source/detector position.
Organ HT [mGy] at 0 mm AR
CA
HT [mGy] at +25 mm AR
CA
HT [mGy] at −25 mm AR
CACA AR CA AR CA AR
Prostate 4.73 ± 0.36 4.64 ± 0.30 0.98 7.91 ± 0.48 8.03 ± 0.73 1.02 3.98 ± 0.07 3.76 ± 0.47 0.94
Bladder 2.31 ± 0.29 2.50 ± 0.69 1.08 3.07 ± 0.90 3.10 ± 1.51 1.01 2.44 ± 0.27 2.27 ± 0.46 0.93
Colon 5.51 ± 1.46 5.86 ± 1.24 1.06 11.37 ± 6.20 13.75 ± 7.78 1.21 6.71 ± 1.00 6.69 ± 0.75 1.00
Skin 36.66 ± 2.40 40.29 ± 4.49 1.10 34.97 ± 2.70 39.49 ± 4.35 1.13 36.69 ± 2.92 42.06 ± 4.62 1.15
Exit 0.54 ± 0.27 0.55 ± 0.09 1.02 0.77 ± 0.11 0.48 ± 0.06 0.62 0.51 ± 0.12 0.63 ± 0.14 1.24
Table 2: Deviation ratios in organ-equivalent dose HT when
moving the X-ray field±25 mm above or below with respect
to the original view (see Table 1). The mean relative error is
46 %.
Organ HT ratio (CA) HT ratio (AR)
+25 mm −25 mm +25 mm −25 mm
Prostate 1.67 0.84 1.73 0.81
Bladder 1.33 1.06 1.24 0.91
Colon 2.06 1.22 2.35 1.41
Skin 0.95 1.00 1.04 0.98
Exit 1.43 0.94 0.87 1.15
pings. The calculated organ-equivalent dose values are jux-
taposed to the associated measurements in Table 3. In gen-
eral, the HT values estimated from MC simulations are in
good agreement with the measured ones for both physical
phantoms concerning the prostate, where an accuracy of 95
% to 99 % is achieved. However, regarding the colon of both
and the bladder of the AR phantom, respectively, deviations
of 12 % to 22 % are observable. The exit dose is underesti-
mated by 13 % to 22 %. Taking the entrance skin dose into
account, divergence of up to 35 % between measured and
simulated HT values for the AR phantom are conspicuous.
Therefore we reiterated the corresponding MC simulations
and replaced the formerly used soft-tissue-equivalent ma-
terial with water, which is commonly used to approximate
soft tissue. These novel MC simulations (ARW; Figure 4d)
resulted in a reduction of the deviation regarding skin dose
to 11 %, while internal HT values still correspond well to the
measurements.
3.4 Impact of material composition
The impact of tissue-equivalent material composition on the
dose deposition is investigated based on the results of the
MC simulations. Table 4 lists the organ-equivalent dose val-
ues HT of the computational R, CA, AR, and ARW phan-
toms as well as the ratio between HT values of the artificial
anthropomorphic phantoms and the reference. The usage of
artificial material compounds leads to an underestimation of
absorbed dose by 8 % for the CA phantom and 28 % for the
AR phantom regarding average skin dose. The highest ac-
cordance concerning skin dose was found with the ARW
phantom, where only a deviation of 1 % occurred. However,
the organ dose deposited in all internal organs is underes-
timated with a deviation of 12 % to 20 %, with all phantom
materials performing comparably. Combining all organs, the
average deviation for the CA phantom is 14 %, 19 % for the
AR phantom, and 14 % for the ARW phantom, respectively.
Concerning effective dose, deviations of 5 % to 12 % with
respect to the reference R can be reported.
The associated deviation maps for an exemplary axial
slice of the three artificially composed phantoms, shown in
Figure 4f, support these findings. Note that noisy distributed,
large deviations in the air and outside of the primary X-ray
beam are mainly due to the overall statistical uncertainty in-
volved when scoring dose distributions directly. Since dose
is deposited by secondary electrons, it can only be scored
when an actual interaction is sampled, thus the evaluation of
the here carried out MC simulations only refers to directly
irradiated body parts. Although there are individual regions
or tissue types where the dose distribution is estimated ac-
curately with respect to the reference R, there are also large
areas where the deviation is significantly greater than 15 %.
4 Discussion
To prevent deterministic and stochastic radiation-induced dam-
age to the patient, interventional X-ray exposure should be
as low as reasonably achievable. To obtain measures for the
expected patient dose in certain procedures, phantom studies
using dedicated anthropomorphic dosimetry phantoms are
in general conducted. This approach, however, introduces
multiple caveats concerning FGIs, which are in general less
predictable than purely diagnostic procedures due to possi-
ble complications and patient specificities. Besides uncer-
tainties associated with the FGI workflow and patient geom-
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(a) R dose (b) CA dose (c) AR dose (d) ARW dose
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Fig. 4: (a)-(d) Axial slice of the digital Golem phantom overlaid with the deposited X-ray dose distribution associated with
each set of material properties. The prostate is located in the center of both the phantom and the X-ray beam. (f) Correspond-
ing percentage deviation maps with respect to the reference R. (e) Spatial relation between dose maps and phantom.
Table 3: Comparison of measured and MC simulated organ-equivalent dose HT for all considered phantoms from irradiation
of the central section interface as shown in Figure 3c. HT is given in terms of mean measurement and standard deviation. The
standard deviation associated with the MC simulations derives from multiple voxels contributing to the organ dose whereas
the standard deviation associated with the measurements derives from multiple MPs and repetitions. The uncertainty of the
MOSFET probes is not included. For the ARW phantom, the measured values of the AR phantom are assumed.
Organ HT [mGy] CA Sim.
Meas.
HT [mGy] AR Sim.
Meas.
HT [mGy] ARW Sim.
Meas.Measured Simulated Measured Simulated Measured Simulated
Prostate 4.73 ± 0.36 4.49 ± 1.44 0.95 4.64 ± 0.30 4.60 ± 1.49 0.99 4.64 ± 0.30 4.50 ± 1.54 0.97
Bladder 2.31 ± 0.29 2.17 ± 0.96 0.94 2.50 ± 0.69 2.18 ± 1.00 0.87 2.50 ± 0.69 2.11 ± 0.97 0.84
Colon 5.51 ± 1.46 6.70 ± 1.07 1.22 5.86 ± 1.24 6.58 ± 0.98 1.12 5.86 ± 1.24 6.58 ± 1.15 1.12
Skin 36.66 ± 2.4 33.66 ± 1.69 0.92 40.29 ± 4.49 26.21 ± 1.43 0.65 40.29 ± 4.49 36.70 ± 1.89 0.89
Exit 0.54 ± 0.27 0.47 ± 0.18 0.87 0.55 ± 0.09 0.47 ± 0.21 0.85 0.55 ± 0.09 0.43 ± 0.20 0.78
etry and placement, the artificial material compounds used
in modern anthropomorphic phantoms often represent an ap-
proximation of mixtures of human tissues, e.g. an averaged
tissue-equivalent material for soft, adipose, and muscular
tissue. While resulting in adequate average linear attenua-
tion coefficients, these mixture materials combined with a
not patient-specific geometry, might not correctly account
for local dose deposition. However, especially with FGIs
concerning the improvement of life quality of otherwise healthy
patients, such as in PAE, accurate estimation of patient dose
is necessary to correctly assess the cost-benefit relation.
Here, we investigated certain sources of uncertainty cor-
related to the determination of organ-equivalent dose val-
ues HT in FGIs on the example of one possible 2D imaging
situation during a PAE procedure. Therefore, we used two
renowned anthropomorphic dosimetry phantoms in combi-
nation with high-sensitivity MOSFET dosimeters to mea-
sure and subsequently calculate the average dose deposited
in internal organs as well as the skin entrance dose. To guar-
antee sensitive MOSFET measurements, we applied unusual
high radiation exposure per measurement, leading to rela-
tively high absolute dose values. In addition, we employed
an MC radiation transport code to reconstruct the experi-
ment digitally to obtain dense dose distributions. This al-
lows, first, to validate the simulation against the experiment,
and second to determine the influence of material compo-
sition and limited sampling points of the phantoms on the
estimated experimental organ doses.
Voxel size may influence simulation output. However,
since we mainly compare the simulation results among each
other, derived conclusions concerning the impact of mate-
rial composition are not affected. In addition, the large slice
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Table 4: Comparison of simulated organ-equivalent dose HT
and effective dose E for the CA, AR, ARW (see Table 3),
and R phantom. HT is given in terms of mean organ dose
over all directly irradiated voxels.
Organ HT [mGy] Ratio
R CA / R AR / R ARW / R
Prostate 5.61 0.80 0.82 0.80
Bladder 2.47 0.88 0.88 0.85
Colon 8.02 0.84 0.82 0.82
Skin 36.50 0.92 0.72 1.01
Exit 0.50 0.94 0.94 0.86
Effective 0.57 mSv 0.89 0.95 0.88
thickness of 5 cm of the physical phantoms and the arrange-
ment of holes in a rectangular grid, only allows for a sparse
sampling of measurement points. Therefore it might be ques-
tionable, whether a finer voxel size would yield significant
improvements. Regarding, the comparison between simu-
lated and measured dose values, however, the influence of
voxel size could be evaluated in more depth in future stud-
ies.
Although both investigated anthropomorphic phantoms
vary considerably in the composition of tissue-equivalent
compounds, the dose values derived from MOSFET dosime-
ter measurements were in accordance within a maximum de-
viation of 8 % in the majority of organs and imaging posi-
tions. However, skin and colon dose showed higher varia-
tions between the two phantoms.
The discrepancy concerning bladder and exit dose values
likely stems from the overall low dose values in these re-
gions leading to high uncertainties of the MOSFET probes.
Dose deposited in the colon, showed a variation up to 22 %,
which could not be accounted for by the slightly different
equipping of the phantoms. Therefore, we conclude, that the
limited amount of dosimetry measurement points are for an
organ with a complex geometry, such as the colon, not suf-
ficient to correctly estimate organ dose. This observation is
also substantiated taking the remaining MC simulated dose
values into account, as they are in overall agreement with
the measurements, only the colon shows a deviation up to
22 % from the experiments. To this end, the importance of
developing and incorporating patient-specific digital twins
is substantiated in order to provide most accurate dose as-
sessment tools.
Regarding skin dose values, the MC simulations yield
ambiguous results. On the one hand, the average skin dose
of the digital CA phantom can be calculated to be in 92 %
accordance with the physical measurements. On the other
hand, a divergence of 35 % is reported for the digital AR
phantom, which leads to the assumption that there is a dis-
crepancy between the digital material model of its soft-tissue-
equivalent and the actual physical plastic. Reiterating the
concerning MC simulation with water instead of the soft-
tissue-equivalent yields comparable results for the internal,
while the deviation in skin dose is considerably lower with
11 %. Whether these findings concerning the several decades
old AR phantom might be due to age- and usage-related ma-
terial wear, could be investigated in the future.
Additionally, the material composition of tissue-mimicking
phantom materials influences the determined organ doses.
The computationally determined organ doses differ addi-
tionally from the reference by up to 28 %. This is for a clin-
ical decision specifically relevant, as all the dose values of
the artificial materials underestimate organ doses compared
to the human reference material. This is further substan-
tiated regarding effective dose, where underestimation by
5 % to 12 % could be observed. To allow for reliable as-
sessment of measured dose values in clinically motivated
phantom studies, this underestimation has to be taken into
account properly.
Finally, we explored the influence of geometric uncer-
tainties, such as patient or X-ray source positioning, on the
organ dose values. Therefore we measured dose values in
the two anthropomorphic phantoms with respect to three
distinct positions along the longitudinal axis of the phan-
toms, uniformly spread over 50 mm. We considered the cen-
tral measurement as baseline and regarded the ratio of the
measurements translated by ±25mm to this reference. The
displacement-induced deviations range from 6 % to 135 %
for the internal organs, only skin dose remains relatively
constant. Regarding the internal organs, deviations are caused
by the altering organ coverage by the primary X-ray field,
thereby changing the scatter-to-primary ratio and the shield-
ing by bones. This leads to the conclusion, that patient po-
sitioning plays a crucial role to correctly assess and man-
age radiation exposure, as small deviations may have a great
impact on organ dose. Future studies might also investigate
the impact of angular variations, since, regarding the case
of PAE for instance, ipsilateral angulation of 25◦ to 35◦ is a
common choice. Also comparing the reference voxel phan-
tom to CT scans of both physical phantoms might allow for
a further in depth analysis.
It has to be additionally considered, that in a clinical
procedure the geometric uncertainty comprises besides po-
sitioning also the geometry of the patient, which may vary
in a much greater extent. Also, slightly divergent projec-
tion geometries applied in the procedure invalidate prospec-
tively determined reference dose values. Therefore, it ap-
pears inevitable to introduce computer-assisted methods to
(a) model or customize a digital twin of the patient and (b)
support the medical staff in registering this patient model
to the actual patient, in order to enable online dose simula-
tion or calculation. Online dose simulation could also yield
3D dose distributions and therefore indicate internal areas of
Pitfalls in interventional X-ray organ dose assessment 9
maximum radiation exposure instead of single reference E
and HT values or sparsely sampled MPs of direct dosime-
ters.
Since it is generally challenging to integrate MC cal-
culations with experimental dosimetry, the reported devia-
tion of 1 % to 5 % concerning the prostate, and 6 % to 13 %
concerning the bladder, respectively, can be considered neg-
ligible and might be due to stochastic fluctuations. Colon
and skin deviations seem to be linked to geometric limita-
tions of the experimental setup, as discussed before. It is
further emphasized, that the simulated phantom geometry
does not match the physical anthropomorphic phantoms ex-
actly, but is modeled to resemble an adult reference male.
Additionally, it has to be considered, that the accuracy of the
dosimeters is limited due to their exposure low dose limit of
1.69 mGy and statistically insignificant energy dependency
[30]. Therefore, and due to comparable validation accuracy
to other computational approaches [31,32,33], we consider
our simulation validated.
5 Conclusion
We demonstrated the impact of using different phantoms,
with focus on tissue material model, and phantom position-
ing on the outcome of prospective phantom dosimetry stud-
ies. Considerable deviations in organ dose estimation due to
uncertainties associated with experimental dosimetry were
found, implying the need for individual patient-specific dose
distribution estimation, e.g. using MC simulation. In addi-
tion, the found deviations deriving from artificial tissue-equivalent
materials underline the need for materials optimized not only
in terms of linear attenuation but also energy absorption.
Future studies will combine the used simulation setup with
advanced patient modeling methods as well as robust algo-
rithms to register and continuously adjust this digital twin to
the actual patient.
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